Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) EBITDA (2016 - 2017)

Historic EBITDA for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q1 2017 value amounting to -$3.9 million.

  • Eledon Pharmaceuticals' EBITDA rose 6602.5% to -$3.9 million in Q1 2017 from the same period last year, while for Mar 2017 it was -$30.4 million, marking a year-over-year increase of 2973.79%. This contributed to the annual value of -$7.5 million for FY2024, which is 6932.13% up from last year.
  • Per Eledon Pharmaceuticals' latest filing, its EBITDA stood at -$3.9 million for Q1 2017, which was up 6602.5% from -$3.7 million recorded in Q4 2016.
  • Eledon Pharmaceuticals' EBITDA's 5-year high stood at -$3.7 million during Q4 2016, with a 5-year trough of -$13.5 million in Q2 2016.
  • Its 5-year average for EBITDA is -$8.3 million, with a median of -$7.7 million in 2014.
  • In the last 5 years, Eledon Pharmaceuticals' EBITDA plummeted by 17105.48% in 2015 and then surged by 6623.65% in 2016.
  • Eledon Pharmaceuticals' EBITDA (Quarter) stood at -$5.5 million in 2013, then fell by 11.88% to -$6.2 million in 2014, then plummeted by 78.48% to -$11.1 million in 2015, then surged by 66.24% to -$3.7 million in 2016, then fell by 3.31% to -$3.9 million in 2017.
  • Its last three reported values are -$3.9 million in Q1 2017, -$3.7 million for Q4 2016, and -$9.3 million during Q3 2016.